Masuda, N., Mukai, H., Inoue, K., Rai, Y., Ohno, S., Ohtani, S., . . . Toi, M. (2020). Analysis of subsequent therapy in Japanese patients with hormone receptor‒positive/human epidermal growth factor receptor 2‒negative advanced breast cancer who received palbociclib plus endocrine therapy in PALOMA-2 and -3. Breast Cancer.
Citação norma ChicagoMasuda, Norikazu, et al. "Analysis of Subsequent Therapy in Japanese Patients With Hormone Receptor‒positive/human Epidermal Growth Factor Receptor 2‒negative Advanced Breast Cancer Who Received Palbociclib Plus Endocrine Therapy in PALOMA-2 and -3." Breast Cancer 2020.
Citação norma MLAMasuda, Norikazu, et al. "Analysis of Subsequent Therapy in Japanese Patients With Hormone Receptor‒positive/human Epidermal Growth Factor Receptor 2‒negative Advanced Breast Cancer Who Received Palbociclib Plus Endocrine Therapy in PALOMA-2 and -3." Breast Cancer 2020.